These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 39057926)

  • 1. Role of Botulinum Toxin in Treatment of Secondary Dystonia: A Case Series and Overview of Literature.
    Mohanty D; Riordan HRM; Hedera P
    Toxins (Basel); 2024 Jun; 16(7):. PubMed ID: 39057926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value.
    Zoons E; Dijkgraaf MG; Dijk JM; van Schaik IN; Tijssen MA
    J Neurol; 2012 Dec; 259(12):2519-26. PubMed ID: 22552527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxins in the treatment of primary focal dystonias.
    Truong D
    J Neurol Sci; 2012 May; 316(1-2):9-14. PubMed ID: 22336699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Focal or Segmental Dystonia Resistant to Botulinum Toxin: How Do You Treat Patients in Whom Botulinum Toxin Treatment Has No Effect?].
    Nomura T
    Brain Nerve; 2022 May; 74(5):581-587. PubMed ID: 35589651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered functional connectivity in blepharospasm/orofacial dystonia.
    Jochim A; Li Y; Gora-Stahlberg G; Mantel T; Berndt M; Castrop F; Dresel C; Haslinger B
    Brain Behav; 2018 Jan; 8(1):e00894. PubMed ID: 29568690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Botulinum toxin for treatment of the focal dystonia].
    Nakamura Y
    Rinsho Shinkeigaku; 2017 Jul; 57(7):367-372. PubMed ID: 28652522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum Toxin Treatment of Motor Disorders in Parkinson Disease-A Systematic Review.
    Jabbari B; Comtesse SM
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum Toxin Therapy in Writer's Cramp and Musician's Dystonia.
    Zakin E; Simpson DM
    Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Botulinum toxin treatment of patients with oromandibular dystonia].
    Erdal J; Werdelin LM; Prytz S; Fuglsang-Frederiksen A; Møller E
    Ugeskr Laeger; 2000 Nov; 162(48):6567-71. PubMed ID: 11187229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis.
    Dadgardoust PD; Rosales RL; Asuncion RM; Dressler D
    J Neural Transm (Vienna); 2019 Feb; 126(2):141-148. PubMed ID: 30604200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystonia: medical therapy and botulinum toxin.
    Jankovic J
    Adv Neurol; 2004; 94():275-86. PubMed ID: 14509685
    [No Abstract]   [Full Text] [Related]  

  • 13. Basis of movement control in dystonia and why botulinum toxin should influence it?
    Wagle Shukla A
    Toxicon; 2024 Jan; 237():107251. PubMed ID: 37574115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment for secondary dystonia.
    Tierney TS; Lozano AM
    Mov Disord; 2012 Nov; 27(13):1598-605. PubMed ID: 23037556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the Use of Botulinum Toxin Therapy for Focal and Task-Specific Dystonias.
    Lungu C; Ahmad OF
    Semin Neurol; 2016 Feb; 36(1):41-6. PubMed ID: 26866495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin therapy of dystonia.
    Dressler D; Adib Saberi F; Rosales RL
    J Neural Transm (Vienna); 2021 Apr; 128(4):531-537. PubMed ID: 33125571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Focal or Segmental Dystonia Resistant to Botulinum Toxin: Re-Evaluation, Surgery, and Botulinum Again].
    Mezaki T
    Brain Nerve; 2022 May; 74(5):575-580. PubMed ID: 35589650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Botulinum Toxin for Treatment of the Dystonias.
    Berardelli A; Conte A
    Handb Exp Pharmacol; 2021; 263():107-126. PubMed ID: 31820178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review.
    Colosimo C; Tiple D; Berardelli A
    Neurotox Res; 2012 Nov; 22(4):265-73. PubMed ID: 22359151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.